PCA3 and cancer: While the wild-type PEG3 promoter is known to be active in many cancers, including PCa cells [17,25], to allow for PET-imaging, the 3STA system can significantly increase the sensitivity of the reporter gene while maintaining promoter specificity, as previously reported with prostate cancer-specific promoter PCA3 [15].